What is Wedbush’s Estimate for APRE FY2029 Earnings?
Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Stock analysts at Wedbush issued their FY2029 earnings estimates for Aprea Therapeutics in a note issued to investors on Tuesday, March 25th. Wedbush analyst R. Driscoll expects that the company will post earnings of $2.19 per share for the year. Wedbush has a “Outperform” rating and a […]
Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Stock analysts at Wedbush issued their FY2029 earnings estimates for Aprea Therapeutics in a note issued to investors on Tuesday, March 25th. Wedbush analyst R. Driscoll expects that the company will post earnings of $2.19 per share for the year. Wedbush has a “Outperform” rating and a […]
